Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies

NCT00492466 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-Remitting Multiple Sclerosis

Interventions

DRUG: Interferon-beta-1a
DRUG: methylprednisolone

Sponsor

Biogen